Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Peter M.O. Wong
Advertisement
Articles by Peter M.O. Wong
Advertisement
Latest Updated Articles
Closing the Gaps in Drug Chain of CustodyPublished: April 28th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
3
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5